Emergence of Escherichia coli producing extended-spectrum AmpC β-lactamases (ESAC) in animals

Frontiers in Microbiology

Volumn 5, Issue FEB, 2014, Pages

  Haenni, Marisa ^a   Châtre, Pierre ^a   Madec, Jean Yves ^a  

^a Lyon Laboratory   (France)

Author keywords

AmpC; Animal; Bovine; ESAC; Escherichia coli

Indexed keywords

CEFEPIME; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN; IMIPENEM; OXYIMINOCEPHALOSPORIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMPC GENE; AMPLICON; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ANALYSIS; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; GENE OVEREXPRESSION; GENETIC RECOMBINATION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; MOLECULAR TYPING; MUTATION; NONHUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; PROMOTER REGION; RECOMBINANT PLASMID; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS;

EID: 84897651121     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00053     Document Type: Article

References (42)

1. Ahmed, A. M., and Shimamoto, T. (2008). Emergence of a cefepime-and cefpirome-resistant Citrobacter freundii clinical isolate harbouring a novel chromosomally encoded AmpC beta-lactamase, CMY-37. Int. J. Antimicrob. Agents 32, 256-261. doi: 10.1016/j.ijantimicag.2008.04.019
2. Barnaud, G., Benzerara, Y., Gravisse, J., Raskine, L., Sanson-Le Pors, M. J., Labia, R., et al. (2004). Selection during cefepime treatment of a new cephalosporinase variant with extended-spectrum resistance to cefepime in an Enterobacter aerogenes clinical isolate. Antimicrob. Agents Chemother. 48, 1040-1042. doi: 10.1128/AAC.48.3.1040-1042.2004
3. Barnaud, G., Labia, R., Raskine, L., Sanson-Le Pors, M. J., Philippon, A., and Arlet, G. (2001). Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate. FEMS Microbiol. Lett. 195, 185-190. doi: 10.1111/j.1574-6968.2001.tb10519.x
4. Brinas, L., Lantero, M., De Diego, I., Alvarez, M., Zarazaga, M., and Torres, C. (2005). Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital. J. Antimicrob. Chemother. 56, 1107-1110. doi: 10.1093/jac/dki370
5. Brinas, L., Zarazaga, M., Saenz, Y., Ruiz-Larrea, F., and Torres, C. (2002). Beta-lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals. Antimicrob. Agents Chemother. 46, 3156-3163. doi: 10.1128/AAC.46.10.3156-3163.2002
6. Carattoli, A. (2008). Animal reservoirs for extended spectrum beta-lactamase producers. Clin. Microbiol. Infect. 1, 117-123. doi: 10.1111/j.1469-0691.2007.01851.x
7. Caroff, N., Espaze, E., Gautreau, D., Richet, H., and Reynaud, A. (2000). Analysis of the effects of -42 and -32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing ampC. J. Antimicrob. Chemother. 45, 783-788. doi: 10.1093/jac/45.6.783
8. Clermont, O., Bonacorsi, S., and Bingen, E. (2000). Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66, 4555-4558. doi: 10.1128/AEM.66.10.4555-4558.2000
9. Corvec, S., Caroff, N., Espaze, E., Marraillac, J., and Reynaud, A. (2002). -11 Mutation in the ampC promoter increasing resistance to beta-lactams in a clinical Escherichia coli strain. Antimicrob. Agents Chemother. 46, 3265-3267. doi: 10.1128/AAC.46.10.3265-3267.2002
10. Corvec, S., Prodhomme, A., Giraudeau, C., Dauvergne, S., Reynaud, A., and Caroff, N. (2007). Most Escherichia coli strains overproducing chromosomal AmpC beta-lactamase belong to phylogenetic group A. J. Antimicrob. Chemother. 60, 872-876. doi: 10.1093/jac/dkm284
11. Cremet, L., Caroff, N., Giraudeau, C., Dauvergne, S., Lepelletier, D., Reynaud, A., et al. (2010). Occurrence of ST23 complex phylogroup A Escherichia coli isolates producing extended-spectrum AmpC beta-lactamase in a French hospital. Antimicrob. Agents Chemother. 54, 2216-2218. doi: 10.1128/AAC.01580-09
12. Crichlow, G. V., Kuzin, A. P., Nukaga, M., Mayama, K., Sawai, T., and Knox, J. R. (1999). Structure of the extended-spectrum class C beta-lactamase of Enterobacter cloacae GC1, a natural mutant with a tandem tripeptide insertion. Biochemistry 38, 10256-10261. doi: 10.1021/bi9908787
13. Dierikx, C., Van Essen-Zandbergen, A., Veldman, K., Smith, H., and Mevius, D. (2010). Increased detection of extended spectrum beta-lactamase producing Salmonella enterica and Escherichia coli isolates from poultry. Vet. Microbiol. 145, 273-278. doi: 10.1016/j.vetmic.2010.03.019
14. Doi, Y., Wachino, J.-I., Ishiguro, M., Kurokawa, H., Yamane, K., Shibata, N., et al. (2004). Inhibitor-sensitive AmpC β-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins. Antimicrob. Agents Chemother. 48, 2652-2658. doi: 10.1128/aac.48.7.2652-2658.2004
15. Guillouzouic, A., Caroff, N., Dauvergne, S., Lepelletier, D., Perrin Guyomard, A., Kempf, I., et al. (2009). MLST typing of Escherichia coli isolates overproducing AmpC beta-lactamase. J. Antimicrob. Chemother. 63, 1290-1292. doi: 10.1093/jac/dkp099
16. Hidri, N., Barnaud, G., Decre, D., Cerceau, C., Lalande, V., Petit, J. C., et al. (2005). Resistance to ceftazidime is associated with a S220Y substitution in the omega loop of the AmpC beta-lactamase of a Serratia marcescens clinical isolate. J. Antimicrob. Chemother. 55, 496-499. doi: 10.1093/jac/dki025
17. Kim, J. Y., Jung, H. I., An, Y. J., Lee, J. H., Kim, S. J., Jeong, S. H., et al. (2006). Structural basis for the extended substrate spectrum of CMY-10, a plasmid-encoded class C beta-lactamase. Mol. Microbiol. 60, 907-916. doi: 10.1111/j.1365-2958.2006.05146.x
18. Le Turnier, S., Nordmann, P., Eb, F., and Mammeri, H. (2009). Potential evolution of hydrolysis spectrum for AmpC beta-lactamase of Escherichia coli. J. Antimicrob. Chemother. 63, 216-218. doi: 10.1093/jac/dkn443
19. Madec, J. Y., Lazizzera, C., Chatre, P., Meunier, D., Martin, S., Lepage, G., et al. (2008). Prevalence of fecal carriage of acquired expanded-spectrum cephalosporin resistance in Enterobacteriaceae strains from cattle in France. J. Clin. Microbiol. 46, 1566-1567. doi: 10.1128/JCM.02299-07
20. Madec, J. Y., Poirel, L., Saras, E., Gourguechon, A., Girlich, D., Nordmann, P., et al. (2012). Non-ST131 Escherichia coli from cattle harbouring human-like blaCTX-M-15-carrying plasmids. J. Antimicrob. Chemother. 67, 578-581. doi: 10.1093/jac/dkr542
21. Mammeri, H., Eb, F., Berkani, A., and Nordmann, P. (2008). Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered in a French hospital. J. Antimicrob. Chemother. 61, 498-503. doi: 10.1093/jac/dkm538
22. Mammeri, H., Guillon, H., Eb, F., and Nordmann, P. (2010). Phenotypic and biochemical comparison of the carbapenem-hydrolyzing activities of five plasmid-borne AmpC beta-lactamases. Antimicrob. Agents Chemother. 54, 4556-4560. doi: 10.1128/AAC.01762-09
23. Mammeri, H., Nazic, H., Naas, T., Poirel, L., Leotard, S., and Nordmann, P. (2004a). AmpC beta-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins. Antimicrob. Agents Chemother. 48, 4050-4053. doi: 10.1128/AAC.48.10.4050-4053.2004
24. Mammeri, H., Poirel, L., Bemer, P., Drugeon, H., and Nordmann, P. (2004b). Resistance to cefepime and cefpirome due to a 4-amino-acid deletion in the chromosome-encoded AmpC beta-lactamase of a Serratia marcescens clinical isolate. Antimicrob. Agents Chemother. 48, 716-720. doi: 10.1128/AAC.48.3.716-720.2004
25. Mammeri, H., Poirel, L., Fortineau, N., and Nordmann, P. (2006). Naturally occurring extended-spectrum cephalosporinases in Escherichia coli. Antimicrob. Agents Chemother. 50, 2573-2576. doi: 10.1128/AAC.01633-05
26. Mammeri, H., Poirel, L., and Nordmann, P. (2007). Extension of the hydrolysis spectrum of AmpC beta-lactamase of Escherichia coli due to amino acid insertion in the H-10 helix. J. Antimicrob. Chemother. 60, 490-494. doi: 10.1093/jac/dkm227
27. Matsumura, N., Minami, S., and Mitsuhashi, S. (1998). Sequences of homologous β-lactamases from clinical isolates of Serratia marcescens with different substrate specificities. Antimicrob. Agents Chemother. 42, 176-179.
28. Mulvey, M. R., Bryce, E., Boyd, D. A., Ofner-Agostini, M., Land, A. M., Simor, A. E., et al. (2005). Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals. Antimicrob. Agents Chemother. 49, 358-365. doi: 10.1128/AAC.49.1.358-365.2005
29. Mulvey, M. R., Susky, E., McCracken, M., Morck, D. W., and Read, R. R. (2009). Similar cefoxitin-resistance plasmids circulating in Escherichia coli from human and animal sources. Vet. Microbiol. 134, 279-287. doi: 10.1016/j.vetmic.2008.08.018
30. Naseer, U., and Sundsfjord, A. (2011). The CTX-M conundrum: dissemination of plasmids and Escherichia coli clones. Microb. Drug Resist. 17, 83-97. doi: 10.1089/mdr.2010.0132
31. Nelson, E. C., and Elisha, B. G. (1999). Molecular basis of AmpC hyperproduction in clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 43, 957-959.
32. Nordmann, P., and Mammeri, H. (2007). Extended-spectrum cephalosporinases: structure, detection and epidemiology. Fut. Microbiol. 2, 297-307. doi: 10.2217/17460913.2.3.297
33. Olsson, O., Bergstrom, S., Lindberg, F. P., and Normark, S. (1983). ampC beta-lactamase hyperproduction in Escherichia coli: natural ampicillin resistance generated by horizontal chromosomal DNA transfer from Shigella. Proc. Natl. Acad. Sci. U.S.A. 80, 7556-7560. doi: 10.1073/pnas.80.24.7556
34. Pitout, J. D. (2012). Extraintestinal Pathogenic Escherichia coli: a combination of virulence with antibiotic resistance. Front. Microbiol. 3:9. doi: 10.3389/fmicb.2012.00009
35. Raimondi, A., Sisto, F., and Nikaido, H. (2001). Mutation in Serratia marcescens AmpC beta-lactamase producing high-level resistance to ceftazidime and cefpirome. Antimicrob. Agents Chemother. 45, 2331-2339. doi: 10.1128/AAC.45.8.2331-2339.2001
36. Rodriguez-Martinez, J. M., Nordmann, P., Ronco, E., and Poirel, L. (2010). Extended-spectrum cephalosporinase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 54, 3484-3488. doi: 10.1128/AAC.00050-10
37. Rodriguez-Martinez, J. M., Poirel, L., and Nordmann, P. (2009). Extended-spectrum cephalosporinases in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 53, 1766-1771. doi: 10.1128/AAC.01410-08
38. Shibata, N., Kurokawa, H., Doi, Y., Yagi, T., Yamane, K., Wachino, J.-I., et al. (2006). PCR classification of CTX-M-type beta-lactamase genes identified in clinically isolated gram-negative bacilli in Japan. Antimicrob. Agents Chemother. 50, 791-795. doi: 10.1128/aac.50.2.791-795.2006
39. Tracz, D. M., Boyd, D. A., Bryden, L., Hizon, R., Giercke, S., Van Caeseele, P., et al. (2005). Increase in ampC promoter strength due to mutations and deletion of the attenuator in a clinical isolate of cefoxitin-resistant Escherichia coli as determined by RT-PCR. J. Antimicrob. Chemother. 55, 768-772. doi: 10.1093/jac/dki074
40. Tracz, D. M., Boyd, D. A., Hizon, R., Bryce, E., McGeer, A., Ofner-Agostini, M., et al. (2007). ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolates. FEMS Microbiol. Lett. 270, 265-271. doi: 10.1111/j.1574-6968.2007.00672.x
41. Vakulenko, S., and Golemi, D. (2002). Mutant TEM beta-lactamase producing resistance to ceftazidime, ampicillins, and beta-lactamase inhibitors. Antimicrob. Agents Chemother. 46, 646-653. doi: 10.1128/AAC.46.3.646-653.2002
42. Valat, C., Auvray, F., Forest, K., Metayer, V., Gay, E., Peytavin De Garam, C., et al. (2012). Phylogenetic grouping and virulence potential of extended-spectrum-beta-lactamase-producing Escherichia coli strains in cattle. Appl. Environ. Microbiol. 78, 4677-4682. doi: 10.1128/AEM.00351-12